Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristopher K Frese

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine CarcinomaMelissa Frizziero, Elaine Kilgour, Kathryn L Simpson, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopyTashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Gut|September 9, 2015
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse modelEva M Serrao, Mikko I Kettunen, Tiago B Rodrigues, et al.
NPJ Genomic Medicine|June 29, 2018
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary originPedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Nature Communications|November 18, 2021
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancerMaximilian W Schenk, Sam Humphrey, A S Md Mukarram Hossain, et al.
Cancer Research|December 17, 2015
PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory PathwaysBrajesh P Kaistha, Holger Lorenz, Harald Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2019
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic CancerMariano Ponz-Sarvise, Vincenzo Corbo, Hervé Tiriac, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine CarcinomaMelissa Frizziero, Elaine Kilgour, Kathryn L Simpson, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2011
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopyTashinga E Bapiro, Frances M Richards, Mae A Goldgraben, et al.
Gut|September 9, 2015
MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse modelEva M Serrao, Mikko I Kettunen, Tiago B Rodrigues, et al.
NPJ Genomic Medicine|June 29, 2018
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary originPedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Nature Communications|November 18, 2021
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancerMaximilian W Schenk, Sam Humphrey, A S Md Mukarram Hossain, et al.
Cancer Research|December 17, 2015
PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory PathwaysBrajesh P Kaistha, Holger Lorenz, Harald Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2019
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic CancerMariano Ponz-Sarvise, Vincenzo Corbo, Hervé Tiriac, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
Pageof 4